Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti‐PD‐1 therapy in hepatocellular carcinoma

Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti‐PD‐1 therapy in hepatocellular carcinoma

Abstract Background The efficacy of immune checkpoint blockade therapy in patients with hepatocellular carcinoma (HCC) remains poor. Although serine‐ and arginine‐rich splicing factor (SRSF) family members play crucial roles in tumors, their impact on tumor immunology remains unclear. This study aim...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jialiang Cai, Lina Song, Feng Zhang, Suiyi Wu, Guiqi Zhu, Peiling Zhang, Shiping Chen, Junxian Du, Biao Wang, Yufan Cai, Yi Yang, Jinglei Wan, Jian Zhou, Jia Fan, Zhi Dai
Format:	Article
Language:	English
Published:	Wiley 2024-11-01
Series:	Cancer Communications
Subjects:	Glycolysis Histone lactylation Immune checkpoint blockade Serine and arginine rich splicing factor 10 Tumor‐Associated Macrophage
Online Access:	https://doi.org/10.1002/cac2.12607
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

LDHA-induced histone lactylation mediates the development of osteoarthritis through regulating the transcription activity of TPI1 gene
by: Junfeng Xia, et al.
Published: (2024-12-01)

Targeting the CLK2/SRSF9 splicing axis in prostate cancer leads to decreased ARV7 expression
by: Jasper Van Goubergen, et al.
Published: (2025-02-01)

Splicing and expression dynamics of SR genes in hot pepper (Capsicum annuum): regulatory diversity and conservation under stress
by: Lin Li, et al.
Published: (2025-01-01)

Lactylation‐Driven IGF2BP3‐Mediated Serine Metabolism Reprogramming and RNA m6A—Modification Promotes Lenvatinib Resistance in HCC
by: Yuanxiang Lu, et al.
Published: (2024-12-01)

Lactate metabolism and histone lactylation in the central nervous system disorders: impacts and molecular mechanisms
by: Yao Wang, et al.
Published: (2024-11-01)

Non-histone lactylation: unveiling its functional significance
by: Pusong Shi, et al.
Published: (2025-01-01)

A landscape of checkpoint blockade resistance in cancer: underlying mechanisms and current strategies to overcome resistance
by: Ginette S. Santiago-Sánchez, et al.
Published: (2024-12-01)

Lactate and Lactylation: Dual Regulators of T-Cell-Mediated Tumor Immunity and Immunotherapy
by: Zhi-Nan Hao, et al.
Published: (2024-12-01)

Lactate metabolism and lactylation in cardiovascular disease: novel mechanisms and therapeutic targets
by: Han Zhang, et al.
Published: (2024-11-01)

The role of lactylation in tumor growth and cancer progression
by: Khulood Al-Malsi, et al.
Published: (2025-02-01)

The role of histone lactylation genes in hepatocellular carcinoma prognostic models and their immune cell infiltration features: a comprehensive analysis of single-cell, spatial transcriptome, Mendelian randomization and experiment
by: Shanjie Luan
Published: (2025-01-01)

Lactate and lysine lactylation of histone regulate transcription in cancer
by: Yunhao Yang, et al.
Published: (2024-11-01)

Dendritic cell effector mechanisms and tumor immune microenvironment infiltration define TLR8 modulation and PD-1 blockade
by: Daniel A. Ruiz-Torres, et al.
Published: (2024-12-01)

PD-L2 act as an independent immune checkpoint in colorectal cancer beyond PD-L1
by: Lvyun Zhu, et al.
Published: (2024-12-01)

Cytoplasmic HMGB2 orchestrates CALR translocation in the course of immunogenic cell death
by: Peng Liu, et al.
Published: (2024-12-01)

Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression
by: Paul G. Pavicic, et al.
Published: (2023-12-01)

The crosstalk between alternative splicing and circular RNA in cancer: pathogenic insights and therapeutic implications
by: Hongkun Hu, et al.
Published: (2024-11-01)

The MHC-I-dependent neoantigen presentation pathway predicts response rate to PD-1/PD-L1 blockade
by: Yuchen Zhang, et al.
Published: (2024-11-01)

Blockade of TIPE2-Mediated Ferroptosis of Myeloid-Derived Suppressor Cells Achieves the Full Potential of Combinatory Ferroptosis and Anti-PD-L1 Cancer Immunotherapy
by: Hafiza Kashaf Tariq, et al.
Published: (2025-01-01)

Editorial: Beyond PD-1: novel checkpoint receptors and ligands as targets for immunotherapy
by: Jesse Haramati, et al.
Published: (2025-02-01)

A novel nanomedicine integrating ferroptosis and photothermal therapy, well-suitable for PD-L1-mediated immune checkpoint blockade
by: Yujun Bao, et al.
Published: (2024-12-01)

Inhibiting HnRNP L-mediated alternative splicing of EIF4G1 counteracts immune checkpoint blockade resistance in Castration-resistant prostate Cancer
by: Xumin Zhou, et al.
Published: (2025-02-01)

PD-L1 (CD274) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma
by: Niklas Klümper, et al.
Published: (2023-12-01)

Multiprong CD38 targeting to enhance anti-PD1 immune checkpoint blockade efficacy
by: Vishnu Vijay Vijayan, et al.
Published: (2024-12-01)

Efficacy and pharmacodynamic effect of anti-CD73 and anti-PD-L1 monoclonal antibodies in combination with cytotoxic therapy: observations from mouse tumor models
by: Brajesh P. Kaistha, et al.
Published: (2024-12-01)

PD-1/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies
by: Menglei Jin, et al.
Published: (2024-11-01)

Mutation of isocitrate dehydrogenase indicates favorable outcomes in pan-cancer immune checkpoint blockade
by: Zhiyang Huang, et al.
Published: (2025-02-01)

Regulatory T cells in immune checkpoint blockade antitumor therapy
by: An Zhang, et al.
Published: (2024-11-01)

PRMT5 promotes ovarian cancer growth through enhancing Warburg effect by methylating ENO1
by: Fei Xie, et al.
Published: (2023-04-01)

Next-generation CTLA-4 targeting molecules and combination therapy: promising strategies for improving cancer immunotherapy
by: Nils-Petter Rudqvist, et al.
Published: (2023-12-01)

Effects of arginine supplementation in high-carbohydrate diets on the growth, hematological parameters, and hepatic and skeletal muscle glucose metabolism of juvenile mirror carp (Cyprinus carpio) based on PI3K/Akt signaling pathway
by: Jinnan Li, et al.
Published: (2024-12-01)

SRSF1 Is Crucial for Maintaining Satellite Cell Homeostasis During Skeletal Muscle Growth and Regeneration
by: Zhenzhen Wang, et al.
Published: (2024-12-01)

Pretreatment with serine protease inhibitors impairs Leishmania amazonensis survival on macrophages
by: Patrícia de Almeida Machado, et al.
Published: (2025-01-01)

Pre-radiation Nivolumab plus ipilimumab in patients with newly diagnosed high-grade gliomas
by: Santosh Kesari, et al.
Published: (2024-12-01)

Serum cytokines as a biomarker for immune checkpoint inhibitor toxicity in patients with pleural mesothelioma
by: Saima Jamil Farooqi, et al.
Published: (2024-12-01)

Deciphering LAG-3: unveiling molecular mechanisms and clinical advancements
by: Alejandra Martínez-Pérez, et al.
Published: (2024-10-01)

A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response
by: Laura Rubio-Pérez, et al.
Published: (2023-12-01)

Splicing factor SRSF1 attenuates cardiomyocytes apoptosis via regulating alternative splicing of Bcl2L12
by: Yilin Xie, et al.
Published: (2024-11-01)

ADA/CD26 axis increases intra-tumor PD-1+CD28+CD8+ T-cell fitness and affects NSCLC prognosis and response to ICB
by: Ornella Franzese, et al.
Published: (2024-12-01)

Neoadjuvant PD-(L)1 blockade with or without chemotherapy versus chemotherapy alone in mismatch repair-deficient, potentially resectable stage III-IVA gastric cancer patients: a single-center retrospective study
by: Xuchen Zhang, et al.
Published: (2024-11-01)